{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:19:38Z","timestamp":1789654778175,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T00:00:00Z","timestamp":1270684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes of most industrialised countries and recently in two African GAVI eligible countries (Rwanda and The Gambia). However the long term effects of PCV are still unclear, as beneficial direct and herd immunity effects might be countered by serotype replacement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A dynamic, age-structured, compartmental model of<jats:italic>Streptococcus pneumoniae<\/jats:italic>transmission was developed to predict the potential impact of PCV7 on the incidence of invasive disease accounting for both herd immunity and serotype replacement effects. The model was parameterised using epidemiological data from England and Wales and pre and post-vaccination surveillance data from the US.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Model projections showed that serotype replacement plays a crucial role in determining the overall effect of a PCV7 vaccination programme and could reduce, negate or outweigh its beneficial impact. However, using the estimate of the competition parameter derived from the US post-vaccination experience, an infant vaccination programme would prevent 39,000 IPD cases in the 20 years after PCV7 introduction in the UK. Adding a catch-up campaign for under 2 or under 5 year olds would provide a further reduction of 1,200 or 3,300 IPD cases respectively, mostly in the first few years of the programme.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This analysis suggests that a PCV vaccination programme would eradicate vaccine serotypes from circulation. However, the increase in carriage of non-vaccine serotypes, and the consequent increase in invasive disease, could reduce, negate or outweigh the benefit. These results are sensitive to changes in the protective effect of the vaccine, and, most importantly, to the level of competition between vaccine and non-vaccine types. The techniques developed here can be used to assess the introduction of vaccination programmes in developing countries and provide the basis for cost-effectiveness analyses.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-10-90","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T18:15:05Z","timestamp":1273256105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease"],"prefix":"10.1186","volume":"10","author":[{"given":"Alessia","family":"Melegaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W John","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"key":"1070_CR1","first-page":"pii","volume":"14","author":"GH De Carvalho","year":"2009","unstructured":"De Carvalho GH, Muscat M, Monnet DL, Giesecke J, Lopalco PL: Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill. 2009, 14: pii-19159","journal-title":"Euro Surveill"},{"key":"1070_CR2","first-page":"1148","volume":"57","author":"CDC","year":"2008","unstructured":"CDC: Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008. MMWR Morb Mortal Wkly Rep. 2008, 57: 1148-1151.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1070_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","volume":"19","author":"SB Black","year":"2000","unstructured":"Black SB, Shinefield HR, Fireman B, Lewis E, Ray P, Hansen JR, et al: Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000, 19: 187-195. 10.1097\/00006454-200003000-00003.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","volume":"21","author":"SB Black","year":"2002","unstructured":"Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al: Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002, 21: 810-815. 10.1097\/00006454-200209000-00005.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","volume":"365","author":"FT Cutts","year":"2005","unstructured":"Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al: Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005, 365: 1139-1146. 10.1016\/S0140-6736(05)71876-6.","journal-title":"Lancet"},{"key":"1070_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","volume":"23","author":"S Black","year":"2004","unstructured":"Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, et al: Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004, 23: 485-489. 10.1097\/01.inf.0000129685.04847.94.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","volume":"362","author":"KL O'Brien","year":"2003","unstructured":"O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, et al: Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 2003, 362: 355-361. 10.1016\/S0140-6736(03)14022-6.","journal-title":"Lancet"},{"key":"1070_CR8","first-page":"893","volume":"54","author":"A Reingold","year":"2005","unstructured":"Reingold A, Hadler J, Farley M, Harrison L, Lynfield R, Thomas A, et al: Direct and Indirect Effects of Routine Vaccination of Children with 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease --- United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005, 54: 893-897.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1070_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2008-3099","volume":"124","author":"SS Huang","year":"2009","unstructured":"Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, et al: Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009, 124: e1-11. 10.1542\/peds.2008-3099.","journal-title":"Pediatrics"},{"key":"1070_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1086\/339525","volume":"185","author":"R Dagan","year":"2002","unstructured":"Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, Janco J, et al: Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002, 185: 927-936. 10.1086\/339525.","journal-title":"J Infect Dis"},{"key":"1070_CR11","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1542\/peds.2004-2338","volume":"116","author":"SS Huang","year":"2005","unstructured":"Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA: Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005, 116: e408-e413. 10.1542\/peds.2004-2338.","journal-title":"Pediatrics"},{"key":"1070_CR12","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1469-0691.2009.02775.x","volume":"15","author":"R Sa-Leao","year":"2009","unstructured":"Sa-Leao R, Nunes S, Brito-Avo A, Frazao N, Simoes AS, Crisostomo MI, et al: Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2009, 15: 1002-1007. 10.1111\/j.1469-0691.2009.02775.x.","journal-title":"Clin Microbiol Infect"},{"key":"1070_CR13","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al: Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007, 297: 1784-1792. 10.1001\/jama.297.16.1784.","journal-title":"JAMA"},{"key":"1070_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1086\/521626","volume":"196","author":"LA Hicks","year":"2007","unstructured":"Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al: Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007, 196: 1346-1354. 10.1086\/521626.","journal-title":"J Infect Dis"},{"key":"1070_CR15","first-page":"144","volume":"57","author":"CDC","year":"2008","unstructured":"CDC: Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep. 2008, 57: 144-148.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1070_CR16","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","volume":"23","author":"TW Hennessy","year":"2005","unstructured":"Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, et al: Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005, 23: 5464-5473. 10.1016\/j.vaccine.2005.08.100.","journal-title":"Vaccine"},{"key":"1070_CR17","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious diseases of humans","author":"R Anderson","year":"1991","unstructured":"Anderson R, May R: Infectious diseases of humans. 1991, Oxford, Oxford University Press, 1991","edition":"1991"},{"key":"1070_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1017\/S002217240002893X","volume":"90","author":"RM Anderson","year":"1983","unstructured":"Anderson RM, May RM: Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond). 1983, 90: 259-325.","journal-title":"J Hyg (Lond)"},{"key":"1070_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1017\/S0950268800004660","volume":"125","author":"WJ Edmunds","year":"2000","unstructured":"Edmunds WJ, Heijden van de OG, Eerola M, Gay NJ: Modelling rubella in Europe. Epidemiol Infect. 2000, 125: 617-634. 10.1017\/S0950268800004660.","journal-title":"Epidemiol Infect"},{"key":"1070_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/aje\/kwi160","volume":"162","author":"CL Trotter","year":"2005","unstructured":"Trotter CL, Gay NJ, Edmunds WJ: Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol. 2005, 162: 89-100. 10.1093\/aje\/kwi160.","journal-title":"Am J Epidemiol"},{"key":"1070_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1017\/S0950268800057976","volume":"114","author":"HR Babad","year":"1995","unstructured":"Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM: Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect. 1995, 114: 319-344. 10.1017\/S0950268800057976.","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"1070_CR22","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/381592","volume":"189","author":"NJ Gay","year":"2004","unstructured":"Gay NJ: The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis. 2004, 189 (Suppl 1): S27-S35. 10.1086\/381592.","journal-title":"J Infect Dis"},{"key":"1070_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.aje.a117238","volume":"140","author":"ME Halloran","year":"1994","unstructured":"Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L: Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994, 140: 81-104.","journal-title":"Am J Epidemiol"},{"key":"1070_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1017\/S0950268800004714","volume":"125","author":"M Brisson","year":"2000","unstructured":"Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G: Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000, 125: 651-669. 10.1017\/S0950268800004714.","journal-title":"Epidemiol Infect"},{"key":"1070_CR25","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3","volume":"18","author":"WJ Edmunds","year":"1999","unstructured":"Edmunds WJ, Medley GF, Nokes DJ: Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med. 1999, 18: 3263-3282. 10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3.","journal-title":"Stat Med"},{"key":"1070_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/imammb\/1.2.169","volume":"1","author":"D Schenzle","year":"1984","unstructured":"Schenzle D: An age-structured model of pre- and post-vaccination measles transmission. IMA J Math Appl Med Biol. 1984, 1: 169-191. 10.1093\/imammb\/1.2.169.","journal-title":"IMA J Math Appl Med Biol"},{"key":"1070_CR27","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1073\/pnas.94.12.6571","volume":"94","author":"M Lipsitch","year":"1997","unstructured":"Lipsitch M: Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA. 1997, 94: 6571-6576. 10.1073\/pnas.94.12.6571.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1070_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3201\/eid0503.990304","volume":"5","author":"M Lipsitch","year":"1999","unstructured":"Lipsitch M: Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis. 1999, 5: 336-345. 10.3201\/eid0503.990304.","journal-title":"Emerg Infect Dis"},{"key":"1070_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3934\/mbe.2008.5.175","volume":"5","author":"KL Sutton","year":"2008","unstructured":"Sutton KL, Banks HT, Castillo-Chavez C: Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia. Math Biosci Eng. 2008, 5: 175-204.","journal-title":"Math Biosci Eng"},{"key":"1070_CR30","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1016\/j.vaccine.2009.05.062","volume":"27","author":"SJ Snedecor","year":"2009","unstructured":"Snedecor SJ, Strutton DR, Ciuryla V, Schwartz EJ, Botteman MF: Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations. Vaccine. 2009, 27: 4694-4703. 10.1016\/j.vaccine.2009.05.062.","journal-title":"Vaccine"},{"key":"1070_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1017\/S0950268805004012","volume":"133","author":"M Hussain","year":"2005","unstructured":"Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, Talukdar R, et al: A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect. 2005, 133: 891-898. 10.1017\/S0950268805004012.","journal-title":"Epidemiol Infect"},{"key":"1070_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jinf.2005.02.008","volume":"52","author":"A Melegaro","year":"2006","unstructured":"Melegaro A, Edmunds WJ, Pebody R, Miller E, George R: The current burden of pneumococcal disease in England and Wales. J Infect. 2006, 52: 37-48. 10.1016\/j.jinf.2005.02.008.","journal-title":"J Infect"},{"key":"1070_CR33","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","volume":"295","author":"KA Poehling","year":"2006","unstructured":"Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al: Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006, 295: 1668-1674. 10.1001\/jama.295.14.1668.","journal-title":"JAMA"},{"key":"1070_CR34","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.vaccine.2004.05.003","volume":"22","author":"A Melegaro","year":"2004","unstructured":"Melegaro A, Edmunds WJ: Cost effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine. 2004, 22: 4203-4214. 10.1016\/j.vaccine.2004.05.003.","journal-title":"Vaccine"},{"key":"1070_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00006454-200302000-00009","volume":"22","author":"KL O'Brien","year":"2003","unstructured":"O'Brien KL, Nohynek H: Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003, 22: 133-140.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR36","volume-title":"CDR Weekly","author":"R George","year":"2001","unstructured":"George R, Melegaro A: Invasive pneumococcal infection England and Wales, 1999. CDR Weekly. 2001, 11:"},{"key":"1070_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1651-2227.2000.tb00776.x","volume":"435","author":"E Miller","year":"2000","unstructured":"Miller E, Waight P, Efstratiou A, Brisson M, Johnson A, George R: Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl. 2000, 435: 11-16. 10.1080\/080352500300051477.","journal-title":"Acta Paediatr Suppl"},{"key":"1070_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1128\/CVI.00344-08","volume":"16","author":"H Lee","year":"2009","unstructured":"Lee H, Nahm MH, Burton R, Kim KH: Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol. 2009, 16: 376-381. 10.1128\/CVI.00344-08.","journal-title":"Clin Vaccine Immunol"},{"key":"1070_CR39","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00006454-200306000-00009","volume":"22","author":"R Dagan","year":"2003","unstructured":"Dagan R, Givon-Lavi N, Zamir O, Fraser D: Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J. 2003, 22: 532-540. 10.1097\/00006454-200306000-00009.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","volume":"28","author":"YB Cheung","year":"2009","unstructured":"Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, et al: Nasopharyngeal Carriage of Streptococcus pneumoniae in Gambian Children who Participated in a 9-valent Pneumococcal Conjugate Vaccine Trial and in Their Younger Siblings. Pediatr Infect Dis J. 2009, 28: 990-995. 10.1097\/INF.0b013e3181a78185.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/aje\/kwm076","volume":"166","author":"A Melegaro","year":"2007","unstructured":"Melegaro A, Choi Y, Pebody R, Gay N: Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol. 2007, 166: 228-235. 10.1093\/aje\/kwm076.","journal-title":"Am J Epidemiol"},{"key":"1070_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/S0950268804001980","volume":"132","author":"A Melegaro","year":"2004","unstructured":"Melegaro A, Gay NJ, Medley GF: Estimating the transmission parameters of pneumococcal carriage in household. Epidemiol Infect. 2004, 132: 433-441. 10.1017\/S0950268804001980.","journal-title":"Epidemiol Infect"},{"key":"1070_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2334-6-14","volume":"6","author":"S Cauchemez","year":"2006","unstructured":"Cauchemez S, Temime L, Valleron AJ, Varon E, Thomas G, Guillemot D, et al: S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis. 2006, 6: 14-10.1186\/1471-2334-6-14.","journal-title":"BMC Infect Dis"},{"key":"1070_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1098\/rstb.1993.0143","volume":"342","author":"GP Garnett","year":"1993","unstructured":"Garnett GP, Anderson RM: Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci. 1993, 342: 137-159. 10.1098\/rstb.1993.0143.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1070_CR45","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","volume":"368","author":"CG Whitney","year":"2006","unstructured":"Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al: Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006, 368: 1495-1502. 10.1016\/S0140-6736(06)69637-2.","journal-title":"Lancet"},{"key":"1070_CR46","unstructured":"Health Protection Agency. 2009, [http:\/\/www.hpa.org.uk]"},{"key":"1070_CR47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/bmj.324.7341.809","volume":"324","author":"CL Trotter","year":"2002","unstructured":"Trotter CL, Edmunds WJ: Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002, 324: 809-10.1136\/bmj.324.7341.809.","journal-title":"BMJ"},{"key":"1070_CR48","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","volume":"5","author":"J Mossong","year":"2008","unstructured":"Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008, 5: e74-10.1371\/journal.pmed.0050074.","journal-title":"PLoS Med"},{"key":"1070_CR49","volume-title":"Pediatr Infect Dis J","author":"S Black","year":"2009","unstructured":"Black S: The Volatile Nature of Pneumococcal Serotype Epidemiology: Potential for Misinterpretation. Pediatr Infect Dis J. 2009."},{"key":"1070_CR50","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1017\/S0950268804002894","volume":"132","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Auranen K, Eichner M: The influence of competition and vaccination on the coexistence of two pneumococcal serotypes. Epidemiol Infect. 2004, 132: 1073-1081. 10.1017\/S0950268804002894.","journal-title":"Epidemiol Infect"},{"key":"1070_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/aje\/kwp351","volume":"171","author":"K Auranen","year":"2010","unstructured":"Auranen K, Mehtala J, Tanskanen A, Kaltoft S: Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children. Am J Epidemiol. 2010, 171: 169-176. 10.1093\/aje\/kwp351.","journal-title":"Am J Epidemiol"},{"key":"1070_CR52","first-page":"251","volume":"50","author":"CP Farrington","year":"2001","unstructured":"Farrington CP, Kanaan MN, Gay NJ: Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Appl Statist. 2001, 50: 251-292.","journal-title":"Appl Statist"},{"key":"1070_CR53","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1098\/rspb.1997.0131","volume":"264","author":"WJ Edmunds","year":"1997","unstructured":"Edmunds WJ, O'Callaghan CJ, Nokes DJ: Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections. Proc R Soc Lond B Biol Sci. 1997, 264: 949-957. 10.1098\/rspb.1997.0131.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"1070_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2334-9-5","volume":"9","author":"N Hens","year":"2009","unstructured":"Hens N, Goeyvaerts N, Aerts M, Shkedy Z, van Damme P, Beutels P: Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium. BMC Infect Dis. 2009, 9: 5-10.1186\/1471-2334-9-5.","journal-title":"BMC Infect Dis"},{"key":"1070_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mbs.2008.12.009","volume":"218","author":"B Ogunjimi","year":"2009","unstructured":"Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, van Damme P, Beutels P: Using empirical social contact data to model person to person infectious disease transmission: An illustration for varicella. Math Biosci. 2009, 218: 80-87. 10.1016\/j.mbs.2008.12.009.","journal-title":"Math Biosci"},{"key":"1070_CR56","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/aje\/kwj317","volume":"164","author":"J Wallinga","year":"2006","unstructured":"Wallinga J, Teunis P, Kretzschmar M: Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol. 2006, 164: 936-944. 10.1093\/aje\/kwj317.","journal-title":"Am J Epidemiol"},{"key":"1070_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009, 360: 244-256. 10.1056\/NEJMoa0800836.","journal-title":"N Engl J Med"},{"key":"1070_CR58","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/JCM.02199-06","volume":"45","author":"IH Park","year":"2007","unstructured":"Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH: Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007, 45: 1225-1233. 10.1128\/JCM.02199-06.","journal-title":"J Clin Microbiol"},{"key":"1070_CR59","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1099\/mic.0.034116-0","volume":"156","author":"PE Bratcher","year":"2010","unstructured":"Bratcher PE, Kim KH, Kang JH, Hong JY, Nahm MH: Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology. 2010, 156: 555-560. 10.1099\/mic.0.034116-0.","journal-title":"Microbiology"},{"key":"1070_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3201\/eid1601.090650","volume":"16","author":"AS Tocheva","year":"2010","unstructured":"Tocheva AS, Jefferies JM, Christodoulides M, Faust SN, Clarke SC: Increase in serotype 6C pneumococcal carriage, United Kingdom. Emerg Infect Dis. 2010, 16: 154-155. 10.3201\/eid1601.090650.","journal-title":"Emerg Infect Dis"},{"key":"1070_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1086\/596064","volume":"199","author":"MH Nahm","year":"2009","unstructured":"Nahm MH, Lin J, Finkelstein JA, Pelton SI: Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis. 2009, 199: 320-325. 10.1086\/596064.","journal-title":"J Infect Dis"},{"key":"1070_CR62","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1086\/593339","volume":"198","author":"IH Park","year":"2008","unstructured":"Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, et al: Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis. 2008, 198: 1818-1822. 10.1086\/593339.","journal-title":"J Infect Dis"},{"key":"1070_CR63","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","volume":"187","author":"AB Brueggemann","year":"2003","unstructured":"Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG: Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003, 187: 1424-1432. 10.1086\/374624.","journal-title":"J Infect Dis"},{"key":"1070_CR64","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/528688","volume":"46","author":"PC Hill","year":"2008","unstructured":"Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, Greenwood BM, et al: Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008, 46: 807-814. 10.1086\/528688.","journal-title":"Clin Infect Dis"},{"key":"1070_CR65","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/505710","volume":"194","author":"KL Sleeman","year":"2006","unstructured":"Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, et al: Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006, 194: 682-688. 10.1086\/505710.","journal-title":"J Infect Dis"},{"key":"1070_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1086\/431524","volume":"192","author":"D Goldblatt","year":"2005","unstructured":"Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, Melegaro A, et al: Antibody Responses to Nasopharyngeal Carriage of Streptococcus pneumoniae in Adults: A Longitudinal Household Study. J Infect Dis. 2005, 192: 387-393. 10.1086\/431524.","journal-title":"J Infect Dis"},{"key":"1070_CR67","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1086\/587941","volume":"197","author":"DM Weinberger","year":"2008","unstructured":"Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, Lipsitch M: Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis. 2008, 197: 1511-1518. 10.1086\/587941.","journal-title":"J Infect Dis"},{"key":"1070_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1086\/599364","volume":"200","author":"SM Granat","year":"2009","unstructured":"Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, Makela PH: Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. J Infect Dis. 2009, 200: 99-106. 10.1086\/599364.","journal-title":"J Infect Dis"},{"key":"1070_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00109-009-0579-4","volume":"88","author":"R Malley","year":"2010","unstructured":"Malley R: Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med. 2010, 88: 135-142. 10.1007\/s00109-009-0579-4.","journal-title":"J Mol Med"},{"key":"1070_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM200102083440602","volume":"344","author":"J Eskola","year":"2001","unstructured":"Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al: Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001, 344: 403-409. 10.1056\/NEJM200102083440602.","journal-title":"N Engl J Med"},{"key":"1070_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/INF.0b013e31819637af","volume":"28","author":"MG Lucero","year":"2009","unstructured":"Lucero MG, Nohynek H, Williams G, Tallo V, Simoes EA, Lupisan S, et al: Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J. 2009, 28: 455-462. 10.1097\/INF.0b013e31819637af.","journal-title":"Pediatr Infect Dis J"},{"key":"1070_CR72","first-page":"S526","volume":"6","author":"D Weycker","year":"2000","unstructured":"Weycker D, Richardson E, Oster G: Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs. Am J Manag Care. 2000, 6: S526-S535.","journal-title":"Am J Manag Care"},{"key":"1070_CR73","first-page":"55","volume":"6","author":"CL Trotter","year":"2003","unstructured":"Trotter CL, Ramsay ME, Slack MP: Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health. 2003, 6: 55-58.","journal-title":"Commun Dis Public Health"},{"key":"1070_CR74","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/bmj.329.7467.655","volume":"329","author":"J McVernon","year":"2004","unstructured":"McVernon J, Trotter CL, Slack MP, Ramsay ME: Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ. 2004, 329: 655-658. 10.1136\/bmj.329.7467.655.","journal-title":"BMJ"},{"key":"1070_CR75","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"CL Trotter","year":"2004","unstructured":"Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME: Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004, 364: 365-367. 10.1016\/S0140-6736(04)16725-1.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-90\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-90.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:57:47Z","timestamp":1711468667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-90","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,8]]},"assertion":[{"value":"9 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"90"}}